BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
토요일, 9월 12

Biodexa Pharmaceuticals PLC

BDRXNASDAQ
Trade with Public
Trade with Public
$1.30
0.6496.94%
가까이에: Sep 11, 5:00 PM EST
$1.20
-0.0954-7.34%
시간외: 7:59 PM EST
실적: H1 2026 실적이 금 9월 11th에 시장 마감 후 발표되었습니다.
개요뉴스실적 전망이벤트목표가재무심리비교주식 보고서

Biodexa Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Biodexa Pharmaceuticals (BDRX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$10000Upside to Avg. PT+830051.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Feb 8, 2024Ladenburg ThalmannAydin HuseynovInitiateBuy$8

Analyst Ratings News

PRO
Watching Biodexa Pharmaceuticals; Zacks Small-Cap Research Gives Stock $10 Price Valuation

Benzinga Newsdesk

PRO
Ladenburg Thalmann Initiates Coverage On Biodexa Pharmaceuticals with Buy Rating, Announces Price Target of $8

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Biodexa Pharmaceuticals (NASDAQ:BDRX) with a Buy rating and announces Price Target of $8.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved